Delays in recommendation of remdesivir for patients with COVID-19 shaped antimicrobial policy in hospitals world over
Delays in recommendation of remdesivir for patients with COVID-19 adversely shaped antimicrobial policy in hospitals around the world, preventing patients from receiving timely remdesivir says The Lancet Respiratory Medicine, at the 30th Conference on Retroviruses and Opportunistic Infections (CROI). Remdesivir is a viral RNA polymerase inhibitor. An individual patient data meta-analysis has added relevant scientific evidence…